Maria Caterina Rotiroti

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 782 citations · Full text

Medicine, Immunology, Oncology +13

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 572 citations · Full text

Medicine, Hematology, Oncology +17

Co-opting signalling molecules enables logic-gated control of CAR T cells

Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh et al. · Nature · 2023 · 292 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia

Silvia Arcangeli, Maria Caterina Rotiroti, Marco Bardelli et al. · Molecular Therapy · 2017 · 153 citations · Full text

Life Sciences, Immunology, Oncology +17

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton et al. · Nature Cancer · 2022 · 110 citations · Full text

Medicine, Neuroscience, Oncology +12